CFTR and gastroesophageal reflux disease: Regarding studies addressing the effects of CFTR modulator therapies on GI symptoms, the prospective study by Zeybel et al. (2017) explored the relation between therapy with ivacaftor (IVA) and extra-esophageal reflux symptoms in n = 12 pwCF [71].